BioSpace News Archive

The medical device outsourcing market size is estimated to worth around US$ 231 billion by 2027 and expanding growth at a CAGR of 9.98% during the forecast period 2020 to 2027.

According to Report, the intranasal drug delivery devices market size is predicted to hit USD 2.98 billion by 2030 and growing at a CAGR of 12.8% from 2021 to 2030.

According to Precedence Research, the high flow nasal cannula market size is estimated to worth US$ 15,926.4 million by 2030 and expanding growth at a CAGR of 11.3% from 2021 to 2030.

The global healthcare cloud infrastructure market size is estimated to hit US$ 157.8 billion by 2030 and is growing at a CAGR of 14.8% from 2021 to 2030.

The global digital patient monitoring devices market size was evaluated at USD 80.61 billion in 2021 and is expected to reach USD 451.54 billion by 2030, at a CAGR of 21.1% from 2021-2030.

The global biotechnology & pharmaceutical services outsourcing market was valued at USD 64.67 billion in 2021 and is expected to hit USD 108.49 billion by 2030, at a CAGR of 5.9% from 2021 to 2030.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.

Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, provided an update on its clinical development programs and announced its development goals for the remainder of 2022.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it has submitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ONS-5010, an investigational therapy which, if approved, will be branded as LYTENAVA™.

ENDRA Life Sciences Inc. announces receipt of Medical Device Quality Management System ISO 13485:2016 and EN ISO 13485:2016 recertification, under Certificate Number MD 697226 from the British Standards Institution.